| Malignant Peripheral Nerve Sheath Tumor studied in …STUDIED_INderived59 of 59show fewer |
|---|
| → studied in | NCT00924196active not recruiting Natural History Study of Patients With Neurofibromatosis Type I · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222413Phase 1 · recruiting Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07298083recruiting DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245500Phase 1 · recruiting Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06515860enrolling by invitation Neurofibromatosis Type 1 Tumor Early Detection Study · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05253131Phase 2 · recruiting Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05642455Phase 1/Phase 2 · recruiting SPEARHEAD-3 Pediatric Study · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549022Phase 1/Phase 2 · recruiting Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02211768Phase 1 · completed Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743554Phase 2 · not yet recruiting Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735820Phase 1/Phase 2 · recruiting Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Epithelioid Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03433183Phase 2 · completed SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897321Phase 1 · recruiting B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05985161Phase 2 · recruiting A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141021recruiting Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04091295available BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872543Phase 2 · recruiting A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849986Phase 2 · recruiting IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03611868Phase 1/Phase 2 · active not recruiting A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530487Phase 2 · terminated Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults · condition mapped CURATED_BROADER · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04811196Phase 1 · completed A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584647Phase 1/Phase 2 · terminated PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02700230Phase 1 · completed Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02452554Phase 2 · completed Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma · condition mapped CURATED_BROADER · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Adult Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02691026Phase 2 · terminated A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03880123Phase 1 · withdrawn Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004853Phase 1 · completed Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02008877Phase 1/Phase 2 · completed SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01661283Phase 2 · completed SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Childhood Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464620Phase 2 · completed Trial of Dasatinib in Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Adult Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00931931Phase 1 · completed HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01418001Phase 1/Phase 2 · terminated Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01653028Phase 2 · completed Alisertib in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Adult Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567046completed Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Childhood Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00837148Phase 2 · completed Sorafenib and Dacarbazine in Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ALIAS · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01777451unknown Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427583Phase 2/Phase 3 · terminated Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors · condition mapped ONTOLOGY_EXACT · 59 trials mapped (24 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |